Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Non-invasive Prenatal Diagnostic Test Based on Fetal DNA Isolated From Maternal Blood

NCT01574781 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT01574781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01574781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Non-invasive Prenatal Diagnostic Test Based on Fetal DNA Isolated From Maternal Blood
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
April 30, 2013
Enrollment
1,781 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chromosome 13 aneuploidy, chromosome 18 aneuploidy, chromosome 21 aneuploidy, other microdeletions, sex chromosome aberrations